Transitions of Care
Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.
Managing CRS, Neurotoxicity, and Infection
Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.
Managing BCMA Bispecifics in the Community
This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.
Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma
Is treatment working? An overview of myeloma treatment history and management over the course of the disease.
Bispecifics in Multiple Myeloma
An overview of bispecific treatments in multiple myeloma.
Survivorship and Self Management
Learn about survivorship and self management strategies for multiple myeloma patients.
Renal Impairment
An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications
CAR-T Therapy
An exciting novel treatment for patients with myeloma
Monoclonal Antibodies
Using the patient’s own immune system to destroy myeloma cells.
How Treatments Are Selected
Is treatment working? An overview of myeloma treatment history and management over the course of the disease.
Myeloma Treatments - Part 1
An overview of myeloma treatments: Steroids, IMiDs, and PIs
Myeloma Treatments - Part 2
Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.